Quick Answer
Caribou Biosciences, Inc. reported Operating Income of -$148.34 million for fiscal year 2025.
Caribou Biosciences, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$148.34M | +11.0% |
| 2024 | -$166.62M | -43.6% |
| 2023 | -$116.06M | -9.1% |
| 2022 | -$106.40M | -58.9% |
| 2021 | -$66.98M | -85.4% |
| 2020 | -$36.12M | -5.3% |
| 2019 | -$34.30M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$29.40M | +23.1% | +38.2% |
| June 30, 2025 | -$47.58M | -9.4% | -10.9% |
| March 31, 2025 | -$42.91M | +6.7% | -12.2% |
| September 30, 2024 | -$38.24M | -161.3% | +12.1% |
| June 30, 2024 | -$43.50M | -32.4% | +5.4% |
| March 31, 2024 | -$46.00M | -47.8% | -214.4% |
| September 30, 2023 | -$14.63M | +44.9% | +55.5% |
| June 30, 2023 | -$32.87M | -15.6% | -5.6% |
- Caribou Biosciences, Inc. showed an increase of +11.0% in Operating Income compared to the prior fiscal year.
- Over the 2019–2025 period, Caribou Biosciences, Inc.’s operating income has declined by 332.4% (from -$34.30 million to -$148.34 million).
- The most recent figure is from Caribou Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: